HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ischemia-reperfusion damage is attenuated by GQ-11, a peroxisome proliferator-activated receptor (PPAR)-α/γ agonist, after aorta clamping in rats.

AbstractINTRODUCTION:
Ischemia-Reperfusion (I/R) damage is one of the major challenges in cardiothoracic surgeries and in a pathological manner, is identified by exacerbated damage signals resulted from blood supply restriction and subsequent flow restoration and re‑oxygenation. I/R damage includes cellular dysfunction and death, impairing tissue and organ function. Inflammation and oxidative stress are known to underlie either ischemia or reperfusion, leaded by HIF, TNF-α, NF-κB, IL-6 and ROS formation. However, the available approaches to prevent I/R damage has been unsuccessful so far. As agonists of peroxisome-proliferation activation receptor (PPAR) are described as transcription factors related to anti-inflammatory factors, we proposed to observe the effects of novel dual agonist, GQ-11, in I/R-related damage.
METHODS:
Male, Wistar rats, 60 days age and 305 g body weight average were treated with vehicle, pioglitazone or GQ-11 (20 mg/kg) for 7 consecutive days and were submitted to aorta clamping for 30 min followed by 3 h of reperfusion. 18F-fluorodeoxyglucose (18F-FDG), an analog of glucose associated with inflammation when accumulated, was observed in liver and bowel by positron emission tomography (PET).
RESULTS:
GQ-11 decreased 18F-FDG uptake in liver and bowel when compared to vehicle and pioglitazone. The treatment also modulated inflammatory markers IL-10, TGF-β, IL-6, IL1-β, TNFα, and CCL-2, besides antioxidant enzymes such as catalase, GPx and SOD.
CONCLUSION:
Inflammation and oxidative stress showed to be important processes to be regulated in I/R in order to prevent exacerbated responses that leads to cell/tissue dysfunction and death. PPAR agonists - including GQ-11 - might be promising agents in a strategy to avoid tissue dysfunction and death after cardiothoracic surgeries.
AuthorsJacqueline Cavalcante Silva, Margherita Bavestrello, Valerio Gazzola, Giovanni Spinella, Bianca Pane, Elena Grasselli, Ilaria Demori, Laura Canesi, Laura Emionite, Michele Cilli, Ambra Buschiazzo, Gianmario Sambuceti, Ivan Rocha Pitta, Marina Galdino Pitta, Patrizia Perego, Domenico Palombo, Dulcineia Saes Parra Abdalla
JournalLife sciences (Life Sci) Vol. 297 Pg. 120468 (May 15 2022) ISSN: 1879-0631 [Electronic] Netherlands
PMID35288175 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Elsevier Inc. All rights reserved.
Chemical References
  • PPAR alpha
  • PPAR gamma
Topics
  • Animals
  • Aorta (pathology)
  • Constriction
  • Male
  • PPAR alpha
  • PPAR gamma (agonists)
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (drug therapy, pathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: